![Øystein Soug](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Øystein Soug
Directeur Général chez
ONCOINVENT ASA
Profil
Øystein Soug currently works at Oncoinvent ASA, as Chief Executive Officer from 2024 and Pharmasum Therapeutics AS, as Director.
Mr. Soug also formerly worked at Oncoinvent ASA (Old), as Chief Executive Officer, Arxx Therapeutics AS, as Chief Executive Officer from 2022 to 2023, Bionor Pharma ASA, as Director in 2013, Orkla ASA, as Chief Financial Officer-Russian Division, Algeta ASA, as CFO, Head-Finance, Administration & IR from 2012 to 2013, and Circio Holding ASA, as Chief Financial Officer from 2021 to 2022.
Mr. Soug received his graduate degree in 1997 from the University of St. Gallen.
Postes actifs de Øystein Soug
| Sociétés | Poste | Début |
|---|---|---|
| ONCOINVENT ASA | Directeur Général | 01/09/2024 |
Pharmasum Therapeutics AS
 Pharmasum Therapeutics AS BiotechnologyHealth Technology Operates as a pharmaceutical company focusses on the discovery and development of novel human medicines for the treatment of brain diseases and neurological diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Øystein Soug
| Sociétés | Poste | Fin |
|---|---|---|
Arxx Therapeutics AS
 Arxx Therapeutics AS BiotechnologyHealth Technology Develops therapeutics for fibrotic diseases | Directeur Général | 01/12/2023 |
| CIRCIO HOLDING ASA | Directeur Général | 20/10/2021 |
Oncoinvent AS
 Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Directeur Général | - |
| ORKLA ASA | Directeur Financier/CFO | - |
Bionor Pharma ASA
 Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Manufactures nutritional supplements and vaccines | Directeur/Membre du Conseil | - |
Formation de Øystein Soug
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
48
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Orkla ASA
 Orkla ASA Food: Specialty/CandyConsumer Non-Durables Supplies branded consumer goods and concept solutions to the grocery and out-of-home sectors | Consumer Non-Durables |
University of St. Gallen
 University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer | Health Technology |
BerGenBio ASA
 BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
Bionor Pharma ASA
Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Manufactures nutritional supplements and vaccines | Health Technology |
Circio Holding ASA
 Circio Holding ASA BiotechnologyHealth Technology Develops active immunotherapy cancer vaccines | Health Technology |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Health Technology |
Pharmasum Therapeutics AS
Pharmasum Therapeutics AS BiotechnologyHealth Technology Operates as a pharmaceutical company focusses on the discovery and development of novel human medicines for the treatment of brain diseases and neurological diseases | Health Technology |
Arxx Therapeutics AS
Arxx Therapeutics AS BiotechnologyHealth Technology Develops therapeutics for fibrotic diseases | Health Technology |
